Company / Operating Cash Flow
BIODESIX INC Operating Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$23.3M
FY2025
5-year range
-$48.6M / -$22.9M
FY2021-FY2025
Trend
+52.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 6 years, ranging from -$49M in FY2024 to -$21M in FY2020.
Based on SEC 10-K filings.
-$23M in FY2025.
Remained stable around -$23M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 52.2% year-over-year.
- Peak operating cash flow was recorded in FY2020.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -4.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$23.3M | +52.2% |
| FY2024 | -$48.6M | -112.7% |
| FY2023 | -$22.9M | +49.1% |
| FY2022 | -$45.0M | -59.3% |
| FY2021 | -$28.2M | -32.1% |
| FY2020 | -$21.4M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026